# A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases

> **NCT07593911** · NA · NOT_YET_RECRUITING · sponsor: **Beijing GoBroad Hospital** · enrollment: 75 (estimated)

## Conditions studied

- Systemic Lupus Erthematosus (SLE)
- Lupus Nephritis (LN)
- Multiple Sclerosis
- Myasthenia Gravis (MG)
- IgG4-Related Diseases
- Rheumatoid Arthritis (RA)

## Interventions

- **DRUG:** MTM-H-001 Injection

## Key facts

- **NCT ID:** NCT07593911
- **Lead sponsor:** Beijing GoBroad Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2030-11
- **Final completion:** 2031-06
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07593911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07593911, "A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07593911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*